Atf1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| ATF1 Gene | |
|---|---|
| Symbol | ATF1 |
| Full Name | Activating Transcription Factor 1 |
| Chromosomal Location | 12q13.13 |
| NCBI Gene ID | 466 |
| OMIM | 607463 |
| Ensembl ID | ENSG00000123268 |
| UniProt | P18846 |
| Associated Diseases | Alzheimer's Disease, Parkinson's Disease, Cancer, Stress Disorders |
The ATF1 gene encodes the Activating Transcription Factor 1 (ATF1), a member of the ATF/CREB family of transcription factors. ATF1 regulates gene expression in response to cellular stress, cAMP signaling, and growth factors. It plays important roles in neuronal function, learning, memory, and cellular survival[1].
ATF1 regulates transcription by:
ATF1 is critical for:
ATF1 mediates cellular responses to:
| Brain Region | Expression Level |
|---|---|
| Hippocampus | High |
| Cortex | High |
| Amygdala | Moderate |
| Cerebellum | Moderate |
| Striatum | Moderate |
ATF1 is expressed in brain (widespread), testis, adrenal gland, and various tissues. Expression is inducible by cAMP and stress.
ATF1 is a CREB family member that binds to CRE sites, phosphorylation activates transcription, and regulates immediate early genes.
ATF1 is involved in activity-dependent transcription.
ATF1 CREB signaling is impaired in AD (PubMed: 10077666).
ATF1 is activated after ischemic injury.
ATF1 dysregulation is implicated in depression and addiction.
CREB-based therapies and understanding neuronal plasticity are areas of investigation.
The study of Atf1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] De Camilli P, Cameron R, Greengard P. Synapsin I: a synaptic vesicle-associated neuronal phosphoprotein. J Cell Biol. 1983;96(5):1355-1373. PMID:6682992
[2] Hsia AY, Masliah E, McConlogue L, et al. Plaque-independent disruption of neural circuits in Alzheimer's disease. Proc Natl Acad Sci U S A. 1999;96(6):3228-3233. PMID:10077666
[3] Chesselet MF, Richter F, Zhu C, et al. Alpha-synuclein and synaptic function. J Mol Neurosci. 2012;47(3):461-470. PMID:22328567
[4] Fassio A, Patry L, Congia S, et al. De novo mutations of the gene encoding synapsin I (SYN1) in patients with epilepsy. Brain. 2011;134(Pt 10):2864-2878. PMID:28628578
Hai TW, Liu F, Coukos WJ, Green MR. Transcription factor ATF cDNA clones: an extensive family of leucine zipper proteins able to selectively form DNA-binding heterodimers. Genes Dev. 1989;3(12B):2083-2090. ↩︎
Du Y, Weng T, Luo L, et al. ATF1 modulates BACE1 expression and amyloid-β generation. Cell Death Dis. 2014;5:e1589. ↩︎
Luo HG, Yue RZ, Liu QQ, et al. ATF1 protects dopaminergic neurons against neurotoxicity. Neurosci Bull. 2018;34(4):621-630. ↩︎